Evidence map›Paper›PMID 27447744›Full record

ArticleOncotarget2016

XIAP RING domain mediates miR-4295 expression and subsequently inhibiting p63α protein translation and promoting transformation of bladder epithelial cells.

Honglei Jin, Jiheng Xu, Xirui Guo, Haishan Huang, Jingxia Li, Minggang Peng, Junlan Zhu, Zhongxian Tian, Xue-Ru Wu, Moon-Shong Tang and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Specificity Proteins (Sp) and Cancer.International journal of molecular sciences · 2023
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Honglei JinZhejiang Provincial Key Laboratory for Technology & Application of Model Organisms, School of Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
Jiheng XuNelson Institute of Environmental Medicine, New York University, School of Medicine, Tuxedo, NY 10987, USA.
Xirui GuoNelson Institute of Environmental Medicine, New York University, School of Medicine, Tuxedo, NY 10987, USA.
Haishan HuangZhejiang Provincial Key Laboratory for Technology & Application of Model Organisms, School of Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
Jingxia LiNelson Institute of Environmental Medicine, New York University, School of Medicine, Tuxedo, NY 10987, USA.
Minggang PengNelson Institute of Environmental Medicine, New York University, School of Medicine, Tuxedo, NY 10987, USA.
Junlan ZhuNelson Institute of Environmental Medicine, New York University, School of Medicine, Tuxedo, NY 10987, USA.
Zhongxian TianNelson Institute of Environmental Medicine, New York University, School of Medicine, Tuxedo, NY 10987, USA.
Xue-Ru WuDepartment of Urology, New York University School of Medicine, New York, NY 10016, USA.
Moon-Shong TangNelson Institute of Environmental Medicine, New York University, School of Medicine, Tuxedo, NY 10987, USA.
Chuanshu HuangZhejiang Provincial Key Laboratory for Technology & Application of Model Organisms, School of Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
New York University · USWenzhou Medical University · CN

Funding

RESEARCH IN ENVIRONMENTAL HEALTH SCIENCES (CENTER GRANT)P30ES000260 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ZELIKOFF, JUDITH TERRY · 1985 to 2020
$26.1M
Reagent/Service CoreP01CA165980 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI TANG, ERIC MOON-SHONG M. · 2013 to 2023
$13.5M
Molecular Mechanisms of Nickel-Induced TumorigenicityR01CA112557 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HUANG, CHUANSHU · 2004 to 2016
$2.9M
Mechanisms underlying therapeutic effect of a new compound Isorhapontigenin (ISO)R01CA177665 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HUANG, CHUANSHU · 2013 to 2018
$1.7M
NCI NIH HHS P01 CA165980NCI NIH HHS R01 CA112557NCI NIH HHS R01 CA177665NIEHS NIH HHS P30 ES000260
6 · The paper itself

Abstract

The X-linked inhibitor of apoptosis protein (XIAP) contains three N-terminal BIR domains that mediate anti-apoptosis and one C-terminal RING finger domain whose function(s) are not fully defined. Here we show that the RING domain of XIAP strongly inhibits the expression of p63α, a known tumor suppressor. XIAP knockdown in urothelial cells or RING deletion in knockin mice markedly upregulates p63α expression. This RING-mediated p63α downregulation is critical for the malignant transformation of normal urothelial cells following EGF treatment. We further show that the RING domain promotes Sp1-mediated transcription of miR-4295 which targets the 3'UTR of p63α mRNA and consequently inhibits p63α translation. Our results reveal a previously unknown function of the RING of XIAP in promoting miR-4295 transcription, thereby reducing p63α translation and enhancing urothelial transformation. Our data offer novel insights into the multifunctional effects of the XIAP RING domain on urothelial tumorigenesis and the potential for targeting this frequently overexpressed protein as a therapeutic alternative.

Indexed as

AnimalsApoptosisCarcinogenesisCell AdhesionCell ProliferationCell Transformation, NeoplasticEpidermal Growth FactorEpithelial CellsGene Expression Regulation, NeoplasticHumansMethionineMiceMice, TransgenicMicroRNAsProtein BiosynthesisProtein DomainsEpidermal Growth FactorMethionineMicroRNAsMIRN4295 microRNA, humanSp1 Transcription FactorTP63 protein, humanTranscription FactorsTumor Suppressor ProteinsXIAP protein, humanX-Linked Inhibitor of Apoptosis Proteinbladder cancer transformationp63αRING domainXIAP

Identifiers

PMID27447744
PMCPMC5302933
OpenAlexW2498420302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.